Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26–30

Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26–30

Abstract Background The benefits of chemotherapy in node-negative, hormone receptor-positive, and human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients with the 21-gene recurrence score (RS) of 18–30, particularly those with RS 26–30, are not known. Methods Using the Survei...

Full description

Bibliographic Details
Main Authors: Seho Park, Yunan Han, Ying Liu, Adetunji T. Toriola, Lindsay L. Peterson, Graham A. Colditz, Seung Il Kim, Young Up Cho, Byeong-Woo Park, Yikyung Park
Format: Article
Language:English
Published: BMC 2019-10-01
Series:Breast Cancer Research
Subjects:
Breast cancer
Chemotherapy
Survival
21-gene recurrence score
Online Access:http://link.springer.com/article/10.1186/s13058-019-1190-4

Internet

http://link.springer.com/article/10.1186/s13058-019-1190-4

Similar Items